Format

Send to

Choose Destination
Cancer Res. 2017 Apr 15;77(8):2134-2147. doi: 10.1158/0008-5472.CAN-15-3490. Epub 2017 Feb 15.

Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors.

Author information

1
Cancer Research Program, Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society, Berlin, Germany.
2
Experimental Pharmacology & Oncology (EPO), Berlin, Germany.
3
Cancer Research Program, Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society, Berlin, Germany. wbirch@mdc-berlin.de.

Abstract

Many tumors display intracellular heterogeneity with subsets of cancer stem cells (CSC) that sustain tumor growth, recurrence, and therapy resistance. Cancer-associated fibroblasts (CAF) have been shown to support and regulate CSC function. Here, we investigate the interactions between CSCs and CAFs in mammary gland tumors driven by combined activation of Wnt/β-catenin and Hgf/Met signaling in mouse mammary epithelial cells. In this setting, CSCs secrete the Hedgehog ligand SHH, which regulate CAFs via paracrine activation of Hedgehog signaling. CAFs subsequently secrete factors that promote expansion and self-renewal of CSCs. In vivo treatment of tumors with the Hedgehog inhibitor vismodegib reduce CAF and CSC expansion, resulting in an overall delay of tumor formation. Our results identify a novel intracellular signaling module that synergistically regulates CAFs and CSCs. Targeting CAFs with Hedgehog inhibitors may offer a novel therapeutic strategy against breast cancer. Cancer Res; 77(8); 2134-47. ©2017 AACR.

PMID:
28202523
DOI:
10.1158/0008-5472.CAN-15-3490
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center